-
FDA approves Bristol-Myers Squibb's, AstraZeneca's Farxiga
SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Bristol-Myers Squibb and AstraZeneca for treating Type 2 diabetes, the agency said Wednesday.
The FDA announced the approval of Farxiga (dapagliflozin) tablets, designed for use with exercise and dietary adjustments to control blood sugar. Type 2 diabetes affects about 24 million people in the United States, accounting for more than 90% of diabetes cases.
-
Mylan launches generic version of Detrol LA
PITTSBURGH — Mylan has launched a generic version of a drug made by Pfizer for treating bladder problems, the company said Tuesday.
Mylan announced the launch of tolterodine tartrate extended-release capsules in the 2-mg and 4-mg strengths. The drug is used to treat overactive bladder with symptoms of urinary incontinence, urgency and frequency.
The drug is a generic version of Pfizer's Detrol LA. Tolterodine tartrate extended-release capsules had sales of about $571.5 million during the 12-month period that ended in September, according to IMS Health.
Minute Maid Juices to Go will welcome two new flavors to its product line. The new blends, Minute Maid Tropical Blend and Minute Maid Berry Blend, are the first Juices to Go products to contain vegetable juice. 
Kids (and kids at heart) have even more reason to be excited about the upcoming film "How to Train Your Dragon 2," thanks to Zak Designs. 
Teva Pharmaceutical Industries has launched an authorized generic version of a drug used to treat overactive bladder, the company said Friday.
Razer, a producer of high-performance gaming hardware, software and systems announced the Razer Adaro series, a new line of headphone designed for entertainment. 